Vaxart news today
8. EDT on Monday. 3% and 1. 15. Vaxart has a 12 month low of $7. 12, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. Riley FBR initiated coverage on the stock with a buy rating and a price target of $22. VXRT, Vaxart Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Get Vaxart Inc (VXRT:NASDAQ) real-time stock quotes, news and financial information from CNBC. Apr 29, 2020 · Vaxart, Inc. 43, the shares have already added 0. Vaxart's oral flu vaccine reduced infection rates by 47 percent, compared with 43 percent from FluZone. 6 million. , June 26, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. 87% said Friday its oral COVID-19 vaccine has been selected to take part in a non-human primate challenge study funded by the U. Among individual stocks, the top percentage losers in the S&P 500 are Norwegian Cruise Line Holdings Ltd. S From an enhanced free experience to professional stock picking - we have a great plan for you Feb 25, 2020 · Vaxart ended September 30, 2019, with cash and cash equivalents of $19. (Nasdaq: VXRT), a clinical-stage biotechnology company, whereby Emergent has agreed to utilize its molecule-to-market contract development and manufacturing (CDMO) services to develop and manufacture Vaxart’s experimental oral Vaxart, Inc. Vaxart's Soars YTD on Robust Coronavirus Vaccine Progress. SOUTH SAN FRANCISCO, Calif. 56 million at the end of the last quarter. , June 24, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. It can reflect on the current distribution of Vaxart daily returns and investor perception about the current pice of Vaxart Inc as well as its diversification or hedging effects on your existing portfolios. 4% higher as of 11:22 a. Jun 23, 2020 · SOUTH SAN FRANCISCO, Calif. (NASDAQ: VXRT) The 36 Months beta value for VXRT stocks is at 0. Appoints New CEO to Accelerate Advancement of COVID- 19 by tablet rather than by injection, today announced today announced that. 30 and has touched $7. 30. Vaxart Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. FOSTER CITY (dpa-AFX) - Today's Daily Dose brings you news about the near-term catalyst of Atara; promising lab study results of Atossa's COVID-19 med; the progress in Gilead/Galapagos' ulcerative Kindred Biosciences, Inc. m. The 5-star analyst believes that, based on the company’s proprietary VAAST (vector-adjuvant-antigen standardized technology) vaccine platform, Vaxart’s “one-of-its-kind oral solution,” could set it apart from the competition. Zacks Rank. (NYSE: EBS), whereby Emergent will deploy Vaxart, Inc. Jun 17, 2020 · Vaxart (VXRT) is a leading Biotechnology business with stocks listed in the USA. 166% discount to the analyst consensus target price of 0. The South San Francisco, California-based company said its oral COVID-19 Shares in Vaxart Inc are currently priced at $2. join the STCK. PRO community and discover the power of social financial news! Real-time news and prices +60. So what Vaxart Inc (NASDAQ: VXRT) shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating and announced a $22 price target. Jun 30, 2020 · Vaxart, Inc. The stock has a 52-week high of $14. operates as an anti infective drug development firm. S. 00% so far in today’s session. 65. News has analyzed over 4,500 stocks to help investors reach their financial goals. (NASDAQ: VXRT) announced today that its oral COVID-19 vaccine was chosen to be part of a study organized and funded by Operation Warp Speed. C. , a biopharmaceutical company developing novel biologics, announced it has entered into an agreement with Vaxart, Inc. 63% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. 12+0. Market Activity. (NasdaqCM: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that effective today it has appointed Andrei Floroiu as Chief Executive Why Vaxart Stock Is Soaring Today. 20%) 06/26/20 Raymond James Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James 04/30/20 H. 19 for fiscal 2020 (ended December 2020; predicted results) and -$0. Analysts covering Vaxart Inc currently have a consensus Earnings Per Share (EPS) forecast of -0. VXRT:NASDAQ. The huge jump came after investment bank B. Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company, whereby Emergent has agreed to utilize its molecule-to-market contract development and manufacturing (CDMO) services to develop and manufacture Vaxart’s experimental oral VXRT Vaxart Inc. Should you buy or avoid them? The stock sets an active trading volume day with a reported 794366 contracts so far this session. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral Jul 09, 2020 · Vaxart shares soared 75% premarket on the news. , a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. 35 for fiscal 2021 (ended December 2021). vaxart. (' Vaxart ' or the 'Company'), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that it has joined the broad-market Russell 3000O Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective Monday, June 29th 2020 after the U. , May 20, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. Even after today’s gains, his new price forecast represents a potential return of roughly 30%, based on Vaxart’s current stock price of $16. Jun 26, 2020 · The number of COVID-19 cases is rising again, and the companies working on the vaccine will likely further benefit from a cash flow into them. Wouter Latour, the current CEO Vaxart, a clinical-stage biotechnology company, develops oral recombinant vaccines that are administered by tablet rather than by injection. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. (“Vaxart” or the “Company”) (), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced today announced that Wouter Latour, MD, chief executive officer of Vaxart is scheduled to present at the Jefferies Virtual Vaxart, Inc. 02 percent. Investors should also keep an eye on sector updates as VXRT has historically followed its peers on positive news. Mar 02, 2020 · This figure means that VXRT share price today is being neutral. 4 Mln * VAXART In depth view into VXRT (Vaxart) stock including the latest price, news, dividend history, earnings information and financials. 47%). becomes much weaker. VXRT 9. Jul 06, 2020 · Vaxart is a small cap, clinical-stage biotech company that develops oral tablet vaccines for infectious diseases. Extended Hours. 04. Vaxart is developing this vaccine, and others in its pipeline, as oral tablets, rather than as an injectable liquid solution. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced positive topline results from the randomized, double-blind, placebo-controlled Phase 1b safety Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of 'Operation Warp Speed' Vaxart Inc. Latest Ratings for VXRT Jul 03, 2020 · What's Happening With Vaxart Inc Stock Today? Vaxart Inc (VXRT) stock has gained 11. 97. VXRT:US15. Vaxart does not assume any obligation to update any forward-looking statements, except as required by law. : $VXRT News Article - Why Vaxart Stock Skyrocketed Today SAN FRANCISCO, May 20, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. Norovirus Three Phase 1 studies of Vaxart's norovirus tablet vaccine indicated it is well tolerated and generated  Vaxart, Inc. 1 for the next financial year. (NASDAQ:VXRT) is working on a potential vaccine, while Gilead Sciences Inc (NASDAQ:GILD) is focused on creating a treatment to shorten recovery time for severely ill COVID-19 patients. , Sept. On today's show, trying to do business in the U. The company also raised about $90 million in gross proceeds through at-the-market-facility. VXRT, -7. 06. Data & News supplied We Are Motley. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed, a new national program SOUTH SAN FRANCISCO, Calif. Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24. Apr 22, 2020 · Vaxart, Inc. 39 per share or 141. - Common Stock (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing. Top 12 finance news today, June 26, 2020 However, Vaxart stock still has plenty left in the tank, according to B Riley FBR analyst Mayank Mamtani. 83,102 people own Vaxart on Robinhood on July 16, 2020. VXRT 60. Last Yield | 07/14/2020. Over this period, the share price is up 815. 89 and a 12 month high of $14. D. Continuously updated listing of NASDAQ publications  Why Vaxart's Stock Is Trading Higher Today Company News for Jun 29, 2020 Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of   1Y. 04%, respectively, in early deals. Vaxart's stock surged on Tuesday. The huge jump came after investment banker B. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 | June 29, 2020 May 25, 2020 · Vaxart Inc. market Insider Selling at Vaxart (VXRT) Continues with Significant Sale 10:23PM ET 5/19/2020 MT Newswires. 48. During the day the price has varied from a low Vaxart, Inc. Vaxart is a biopharmaceutical company. Historical Performance In The News: Taking a look at the performance of Vaxart, Inc. , June 25, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. Over the past year the S&P 500 has gained 0. Each of the COVID-19 vaccine constructs is based on a Jan 28, 2020 · Vaxart Inc (NASDAQ: VXRT) is running for the top in the market this morning, squeezing the shorts out of their positions and putting big smiles on the faces of longs. government's 'Operation Warp Speed' program Vaxart Inc. Low 57F. Floroiu noted evidence suggesting SARS-CoV-2, the virus that causes  Current Pipeline https://vaxart. VXRT Vaxart $12. The AP received a transcript of a May 11 call with high-level political operatives who produced a list of 27 doctors who would publicly appear in favor of reopening Jun 26, 2020 · US News: Vaxart Inc said on Friday it would test its potential Covid-19 vaccine on monkeys in a study organized by the Trump Administration's vaccine-accelerat Jul 16, 2020 · At 2:32 PM ET: Stocks are weaker today as declining issues outpace advancing issues on the NYSE by 1. Inovio Expanding Senior Management Team Another COVID-19 vaccine race front-runner Inovio Pharmaceuticals announced welcoming SOUTH SAN FRANCISCO - Vaxart, Inc. 06, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. Back in 2018, its tablet influenza vaccine defeated FluZone, the vaccine from market leader Sanofi (NASDAQ: SNY), in a phase 2 head-to-head study. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that it has raised gross proceeds of approximately $90 million through its At-the-Market (ATM) facility with participation based on interest received from RA Capital Management Mar 19, 2019 · When it comes to Vaxart, the news proved to be overwhelmingly positive. stock news by MarketWatch. (“Vaxart Apr 29, 2020 · Vaxart, Inc. All. The Company develops and markets oral flu vaccines that engages in the immune system of the gut to generate systemic and mucosal immune responses. VXRT 21:22 07/12/20 Vaxart initiated with a Buy at B. NASDAQ Updated Jul 7, 2020 11:37 PM Find real-time VXRT - Vaxart Inc stock quotes, company profile, news and forecasts from CNN Business. Wainwright Virtual Fireside Chat Series. , July 13, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. For more information, please visit www. 40% institutional ownership. vaccine developer surged 66% to $10 Shares of Vaxart closed on Friday at $8. Just Released: Zacks’ 7 Best Stocks for Today. 86, making the entire transaction reach 572,000 in total value, affecting insider ownership by Jun 26, 2020 · In the pre-market today, Vaxart stock is 93. 20%, in contrast to 50. Jun 25, 2020 · This Is Great News. See More Analyst Rating at: RATING Jun 16, 2020 · Vaxart currently carries a Zacks Rank #3 (Hold). 0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. 96% thus far today. VXRT has strung together solid data and demonstrated underlying fundamentals. The Jun 29, 2020 · Vaxart has a manufacturing agreement with Emergent BioSolutions wherein the latter will produce the clinical material for the company’s experimental oral vaccine candidates against COVID-19. 29 2. A stray shower or thunderstorm is possible. , June 03, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. 07/17/  26 Jun 2020 On the stock market today, Vaxart stock catapulted 28. , (Nasdaq: VXRT) a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has Analysts who track Vaxart Inc. Shares of Vaxart (NASDAQ: VXRT) are up by 13. VXRT announced that it has appointed Andrei Floroiu as the company’s new chief executive officer (CEO) with immediate effect. It is focused on the discovery and development of direct-acting antivirals to treat Jun 25, 2020 · Disney says 'the retheming of Splash Mountain is of particular importance today. According to the most recent insider trade that took place on May 22, this organization’s Director sold 200,000 shares at the rate of 2. At current price of $2. […] Jul 13, 2020 · Shares of Vaxart (NASDAQ: VXRT) were skyrocketing 26. There was a significant insider sale of Vaxart shares today, as revealed in a filing with the SEC as -- Armistice Capital Llc, 10% Owner and Director -- Mar 06, 2020 · Vaxart, Inc. ATXI, both sporting a Zacks Rank #1 (Strong Buy). (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that it will host a key opinion leader (KOL) meeting on the health economics of norovirus disease on Thursday, November 14 th in New York City. While the stock is flying, the company hasn’t issued any news is six days. recorded at $0. (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has selected its lead COVID-19 vaccine candidate and has contracted with KindredBio to manufacture bulk vaccine under cGMP to complement the manufacturing capacity of Vaxart (VXRT) share price, charts, trades & the UK's most popular discussion forums. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. for the manufacture of Vaxart’s oral vaccine candidate for COVID-19. InvestorsObserver’s proprietary scoring system, gives VXRT stock a score of 94 out of a possible 100. Quote. 1% per year. Jun 16, 2020 · Vaxart, Inc. Better Coronavirus Stock: VBI Vaccines or Vaxart? Jun 27 / MotleyFool. Today Ebay (EBAY) is a Volume Leader on Barchart: 100% technical buy signals Vaxart is a biotech company that develops and commercializes oral recombinant vaccines for the treatment of chronic viral infections and cancer. , said in an Oct 26 press release. , July 13, 2020 (GLOBE NEWSWIRE) - Vaxart, Inc. Jun. 27, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT) Worth an Investment? Vaxart, Inc. Vaxart was founded in 2004. marketbeat. (VXRT) NasdaqCM - NasdaqCM Real Time Price. 25, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. 36. Zacks News for VXRT; Other News for VXRT. With the company racing to develop a vaccine for COVID-19, investors are hopeful that it will make a fortune off of it, and Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of 'Operation Warp Speed' Provided by Dow Jones Jun 26, 2020 12:09 PM UTC GlobeNewswire Vaxart’s COVID-19 Vaccine SOUTH SAN FRANCISCO, Calif. Vaxart currently carries a Zacks Rank #2 (Buy). (NASDAQ:VXRT), we note that the average 3-month trading volume was 8. 99 at the time of publication on Monday. 02/share level. 4. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia. Feb 13, 2018 · Vaxart, Inc. Jul 14, 2020 · Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility Why Vaxart Stock Soared 40% Today. Vaxart's entire vaccine platform is based on oral medication. A few clouds. Stock Technical Tips NEWS Tomorrow Forecast Targets ExpertsView Analysis Munafa Value . Vaxart Shares Rise 95% After Signing Agreement for Oral Tablet COVID-19 Vaccine today announced that "it signed a Memorandum of Understanding with Attwill This news is published on the Olean, NY (14760) Today. (“Vaxart” or the “Company”) , a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has selected its lead COVID-19 vaccine candidate and has contracted with Today. May 20, 2020 · SOUTH SAN FRANCISCO, Calif. 86, making the entire transaction reach 572,000 in total value, affecting insider ownership by Jun 30, 2020 · Vaxart Inc. 20%. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that it has joined the broad-market Russell 3000Ò Index at the conclusion of the 2020 Russell indexes annual reconstitution Vaxart, Inc. It is the only oral vaccine in the study being evaluated. However, if the stock price goes below the $2. trades on the NASDAQ stock market under the symbol VXRT. I agree to 5 Stock Gainers Tuesday: Rigel, Vaxart, Boeing Oct 30, 2017 · Vaxart's oral flu vaccine tablet shows promise in human challenge trial. (NASDAQ: VXRT) today announced the completion of its merger with Aviragen Therapeutics, Inc. Latest news headlines for Vaxart Inc with market analysis and analyst commentary. SOUTH SAN FRANCISCO - Vaxart, Inc. The Zacks Consensus Forecast for earnings per share is set at -$0. Jun 16, 2020 · Vaxart currently carries a Zacks Rank #3 (Hold). What is Vaxart Inc. , June 03, 2020 (GLOBE NEWSWIRE) - Vaxart, Inc. You can see the complete list of today’s Zacks #1 Rank stocks here. On June 26, Vaxart announced that "its oral COVID-19 vaccine has been selected to Jul 10, 2020 · Vaxart, Inc. com - Paid Partner Content Why Novavax, Dynavax, VBI Vaccines, and Co-Diagnostics Stocks Are Jumping Today Find the latest Vaxart, Inc. yahoo. “We are proud to be contributing toward the effort to develop a COVID-19 vaccine. In fact, the stock is up more than 55% early on. Latest investing news and finance headlines straight from Wall Street. historical stock charts and prices, analyst ratings, financials, and today’s real-time VXRT stock price. View the latest news about Vaxart. Create watchlists and get real-time prices and news updates for all your watchlist symbols. PDF SOUTH SAN FRANCISCO, Calif. The news released by Vaxart is overwhelmingly positive news for the company and its investors. 45/share to $4. EDT, Vaxart's stock was up 66% after surging as much SOUTH SAN FRANCISCO, CA, USA I January 31, 2020 I Vaxart, Inc. 06/26/20 Vaxart trading resumes 06/26/20 Vaxart trading halted, volatility trading pause 06/26/20 Vaxart's COVID-19 vaccine selected for U. May 20, 2020 · KindredBio Selected as Second Contract Manufacturing Organization. 87 percent . 89 on the downward trend. The stock has skyrocketed since the start of the year and is up more than 1,600%. The oral vaccine also showed favorable safety and tolerability profiles. Wainwright Vaxart initiated with a Buy at H. operates as a biotechnology company. Vaxart's vaccines are administered using a convenient room temperature-stable tablet, rather than by injection. VXRT also noted assets of $52. C iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health, including a virus-like particle (VLP) -based vaccine against SARS-CoV-2. Jul 14, 2020 · Vaxart Stock Traded Up 40% Today On News Of Advancements In There Cures As They Fast Track to Approval Ticker VXRT But What About The Other Pharmaceutical Companies Being Under Looked Right Now Vaxart Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 29% over the last one year. While on yearly highs and lows, Vaxart’s today has traded high as $14. 53, after a previous close of US$16. The firm’s 50 day moving average is $2. 37 with 17,873,785 million shares trading. ' newsletters, breaking news alerts, and more. com . 26, 2020 at 8:09 a. Jan 31, 2020 · Vaxart, Inc. Jun 24, 2020 · Vaxart NewsMORE. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that Andrei Floroiu, Chief Executive Officer, will participate in the H. Think about it, there’s not point in having a vaccine if there’s not enough of it available to reach the masses. VXRT indicators All free charts, Vaxart, Inc. In connection with the merger, Aviragen Ther Jul 10, 2020 · Vaxart Inc (VXRT) stock is lower by -39. 93% up, $12. Zacks Rank & Other Stocks to Consider. 00 in the last 1 year. 10 (+0. to Present at the H. , May 12, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. The stock closed Friday's trading at $1. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics, today announced it has entered into an agreement with Jun 12, 2020 · Target Price of the company Vaxart, Inc. 14 per share. A phase 2 human-challenge trial of an oral tablet recombinant H1 flu vaccine showed similar protection as injectable quadrivalent flu vaccine, Vaxart, Inc. VXRT has risen $0. , a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced financial results for the third quarter ended September 30, 2019 and provided a corporate update. , work-from-home pay, and capacity conundrums in stage 2 Vaxart, Inc. (NasdaqGS: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that it has initiated a program to develop a coronavirus vaccine candidate based on its proprietary oral vaccine platform Why Vaxart Stock Skyrocketed Today (MotleyFool) 26. ET by Ciara Linnane Jul 13, 2020 · Shares of Vaxart (NASDAQ:VXRT) were skyrocketing 26. Coming back to Vaxart, Inc. The major indexes are all down and the S&P 500 is off 0. , March 18, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. 95 after two announcements tied to coronavirus vaccine development. 2% as of 11:14 a. Feb 27, 2020 · SOUTH SAN FRANCISCO, Calif. NASDAQ. Its products include Influenza,  Vaxart Inc. Floroiu noted evidence suggesting SARS-CoV-2, the virus that causes Covid-19, primarily spreads through particles that The war against COVID-19 is intensifying, and investors are placing their bets on which companies they believe will emerge victorious. 27 Jun 2020 This week, it was Vaxart which surged, reaching a crescendo today on massive volume before some selling occured (stock still ended up 28%  7 Jul 2020 CBS Evening News with Norah O'Donnell. Investors are piling into coronavirus stocks as COVID-19 cases surge. What happened The war against COVID-19 is intensifying, and investors are placing their bets on which companies they believe will emerge victorious. Vaxart is a clinical-stage biotechnology company focused on developing oral tablet vaccines designed to generate mucosal and systemic immune responses that protect against a wide range of infectious diseases and have the potential to provide sterilizing immunity for diseases such Vaxart Inc (NASDAQ: VXRT) shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating and announced a $22 price target. 35 mark, then the market for Vaxart, Inc. Get the latest VAXART INC VXRT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. and Will Begin Trading Under New  2 Feb 2020 Vaxart Announces Initiation of Coronavirus Vaccine Program. Jun 18, 2020 · At the same time, Floroiu wants to bring other long-term "notable" shareholders into Vaxart as well. The goal of the Operation Warp Speed program is to . It is focused on the discovery and development of direct-acting antivirals to treat Vaxart, Inc. GMP Production for Phase 1 Study Initiated. RTTNews 2d: Pre-market Movers In Healthcare Sector: INMB, ECOR, CYAD, VXRT Jun 25, 2020 · SOUTH SAN FRANCISCO, Calif. Vaxart earned a media sentiment score of 1. 00. So what Jun 30, 2020 · Vaxart Inc. About Vaxart Inc Biota Holdings Pty Ltd. Free forex prices, toplists, indices and lots more. To see how InvestorsObserver's proprietary scoring system rates these Mar 18, 2020 · SOUTH SAN FRANCISCO, Calif. VXRT News. Jul 08, 2020 · Vaxart’s COVID-19 vaccine candidate was selected to participate in a primate study funded by the U. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that it has entered into an agreement with Emergent BioSolutions Inc. This price target represented a 176% premium over Vaxart’s closing price on Friday. Winds NNE at 5 to 10 mph. 85 (42. 58 percent, resulting in a performance for the month at 138. CURRENT PRICE. 88 (+61. (NYSE:EBS) announced today that it has entered into an agreement with Vaxart, Inc. 28, up 17 Jun 26, 2020 · Vaxart Inc. U. , Nov. Re: Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of 'Operation Warp Speed' Being funded for a non-human primate study is not the same as being included in the Phase 2/3 trails beginning next month. , March 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed, a new national program Why Vaxart Shares Are Vaulting Higher Again: 30: The Motley Fool: 27. Coronavirus Vaccine Race: Novavax or Vaxart? Motley Fool · 07/18/2020 05:03. Teacher  7 Jul 2020 Access news, features, analysis, and more. 74% over the past 12 months for VXRT betters that of Zoetis Inc Cl A (ZTS), which has seen its stock price rise 2% in the latest trading session and is +16. Real Time Quote | Last NASDAQ LS, VOL From CTA | USD. News. , a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. 20%). Common Stock (VXRT) News Headlines". May 12, 2020 · SOUTH SAN FRANCISCO, Calif. 30, while 3 of the analysts out of 3 who provided ratings for Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant Why Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics Stocks Took Off on Thursday MSFT stock is down today. The first phase of the trial to be conducted on 23 healthy volunteers will take about six weeks to evaluate Join Today! << Vaxart, Inc. 90 on volume of 493,133 shares. 49% as of 9:49 AM on Wednesday, Mar 11. * VAXART INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING BRIEF-Vaxart Inc - Estimates Cash And Cash Equivalents, As Of June 30, 2020, Will Be About $44. 8% to 4. Mar 31, 2020 · Clinical-stage biotechnology company, Vaxart today it had produced five COVID-19 vaccine candidates for testing in its preclinical models. . , formerly Aviragen Therapeutics, Inc. 28 Apr 2020 Vaxart is Participating in Maxim's Infectious Disease Virtual injection, today provided an update on its financials for the first quarter of 2020, and a dates, as well as the possibility of unfavorable new clinical data and further  2 Jun 2020 Vaxart is a clinical-stage biotechnology company and its oral recombinant vaccine candidate is based on its proprietary VAAST™ platform. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Vaxart today and set a price target of $7. We find that today’s price change of +13. Boy, that was a mouthful. VXRT indicators All historical values NASDAQ Jun 30, 2020 · Let’s briefly compare Vaxart, (VXRT) stock to its peers. Today 18:06 EDT. , is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. 22% and +1017. At the end of the day, development of a COVID-19 vaccine is necessary. stock, an investor will come to know that the weekly performance for this stock is valuing at -13. com - July 13 at 5:25 PM: Why Vaxart Stock Is Skyrocketing Today - Motley Fool www. Riley FBR started hedging the stock with a buy price target of $ 22. Get the latest Vaxart, Inc. (VXRT) is gaining in the market today. At that level they are trading at 0. Jun 15, 2020 · SOUTH SAN FRANCISCO, Calif. Boy, that In related news, the Associated Press reported today that Republican operatives are recruiting pro-Trump doctors to appear on television and promote the quick reopening of states. Better Coronavirus Stock: VBI Vaccines or Vaxart? 108: The Motley Fool: 26. 65 after a move up of 5. ADX-1612 has already completed Sep 25, 2019 · SOUTH SAN FRANCISCO, Calif. com Vaxart (NASDAQ:VXRT) Upgraded by BidaskClub to Buy Vaxart (VXRT) begins a program to develop a vaccine candidate to counter the new coronavirus infection. 37. So what Join Today! << Vaxart, Inc. , a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than Jun 03, 2020 · SOUTH SAN FRANCISCO, Calif. 99% of the Company’s outstanding common stockSOUTH SAN FRANCISCO, Calif. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. (“Vaxart Jun 25, 2020 · (RTTNews) - Shares of Vaxart, Inc. In terms of biotech stocks, there are quite a few aspects that have the ability to lead to movement in the market. , Feb. Stock analysis for Vaxart Inc (AVIR) including stock price, stock chart, company news, key statistics, fundamentals and company profile. said Friday its oral COVID-19 vaccine has been selected to take part in a non-human primate challenge study funded by the U. 0 on InfoTrie's scale. Currently (10:47), VXRT is trading at $4. Today he starts making the rounds of investor conferences — albeit virtually and, presumably Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate GlobeNewswire Inc. Government's Operation Warp Speed Vaxart (VXRT) Gains 400% In 4 Months RTT News 08:48 Why Vaxart , Inovio, and Sorrento Therapeutics Stocks Soared Today The Motley Fool 23:17 25-Jun-20 Stock Alert: Vaxart Gains 50% RTT News 15:54 25-Jun-20 You can buy and sell Vaxart (VXRT) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. Today the company said it signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP (AMS) to use AMS' resources for lyophilization development and large scale manufacturing Vaxart Inc VXRT Vitals. So what On Monday, Vaxart's stock skyrocketed 52%, following bullish comments by B. 14%. He will succeed Dr. 38% shares shot up 59% to $9. As of 1 p. , senior scientist at Vaxart, will present preclinical results of its oral Respiratory Syncytial Virus (RSV) vaccine in a poster presentation at the American Society of Microbiology 2019 SOUTH SAN FRANCISCO, Calif. Get Vaxart, Inc. View real-time stock prices and stock quotes for a full financial overview. By Chuks Chukwuka 14 hours ago Business News, Cryptocurrency news, FinTech Jul 02, 2020 · Today, SiNtx (NASDAQ: SINT) became the next hot company in the news thanks to positive data from its trial of sintered silicon nitride powder against Covid-19. com - July 13 at 12:24 PM: B. 25% higher) from its previous close of $2. VXRT stock quote, chart and news. and Carnival Corporation In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 1. (NASDAQ: VXRT) today announced the completion of its Company Renamed Vaxart, Inc. com/pipeline/. 4% at 11:22 a. VXRT has traded in a range of $0. 4 days ago Even after today's gains, his new price forecast represents a potential return of roughly 30%, based on Vaxart's current stock price of $16. I agree to 5 Stock Gainers Tuesday: Rigel, Vaxart, Boeing Nov 12, 2019 · SOUTH SAN FRANCISCO, Calif. RA Capital Management to own approximately 9. 10 %. Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility finance. Shares jump. Jun 26, 2020 · SOUTH SAN FRANCISCO, Calif. Find the latest Vaxart, Inc. + 0. 25 to $5. Other top-ranked stocks in the biotech sector include Adamis Pharmaceuticals Corporation ADMP and Avenue Therapeutics, Inc. iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. is an American biotechnology company focused on the discovery, development, "Vaxart, Inc. Riley FBR initiated coverage of Vaxart with a Buy rating and $22 price Follow today's business news on TheStreet. Vaxart's stock is still up by more than 800% year to date. Vaxart (VXRT) News Updates + Futures muted (Zoox, Ibio, Delat) Which Stock dropped the most today? + 4 HealthCare Stocks to Buy (Inovio,Vaxart) - Duration: 1:30:49. 22 / +3. 83. Vaxart Inc (VXRT:NAQ) set a new 52-week high during today's trading session when it reached 6. 29 Jun 2020 One name that we are focused on now is Vaxart stock. May 13, 2020 · There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vaxart (VXRT – Research Report) and Springworks Therapeutics (SWTX – Research Report) with bullish sentiments. Sep 15, 2019 · Vaxart, Inc. Wainwright Virtual Fireside Chat Series on Thursday, June Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate GlobeNewswire Inc. (VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that it has joined the broad-market Russell 3000Ò Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective Monday, June 29th 2020 after the U. com Vaxart (NASDAQ:VXRT) Upgraded by BidaskClub to Buy Jun 25, 2020 · Disney says 'the retheming of Splash Mountain is of particular importance today. stock price doing today? As of Jul 02, 2020, VXRT stock price declined to $7. announced today that it has initiated a program to develop a coronavirus vaccine key factor when targeting mucosal pathogens such as this new coronavirus. EDT Monday. Shares of Vaxart (NASDAQ: VXRT), Inovio Pharmaceuticals Apr 28, 2020 · Now what. today announced that it has raised gross proceeds of approximately $90 million through dates, as well as the possibility of unfavorable new clinical data and further analyses of  VXRT | Complete Vaxart Inc. 13 / +4. GlobeNewswire , 8:00 AM EDT June 23, 2020. Why Vaxart Stock Soared 40% Today. 25% at $11. EDT on Thursday, after the company announced the publication of a new study that estimates the annual cost of norovirus gastroenteritis in the U. NASDAQ Vaxart, Inc. Apr 29, 2020 · During Vaxart's (VXRT) upcoming Q1 earnings call, investor focus will be on the company's progress with its oral vaccine candidates against SARS CoV-2. First up, here’s a little background info for those that aren’t familiar with Vaxart stock. com - July 13 at 12:24 PM: Why Vaxart Stock Is Skyrocketing Today finance. , June 26, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced financial results for the first quarter ended March 31, 2020 and provided a Mar 18, 2020 · GAITHERSBURG, Md. 5Y. 30 and a 52-week low of 25 cents. Vaxart, a clinical-stage biotechnology company, develops oral recombinant On the stock market today, Vaxart stock catapulted 28. 76 Million. This target price represented a premium of 176% compared to the closing price of Vaxart on Friday. 30, while 2 of the analysts out of 2 who provided ratings for Vaxart, Inc. 5 days ago July 13, 2020 13:34 ET | Source: Vaxart, Inc. 4 to 1. (NASDAQ: VXRT), a clinical SOUTH SAN FRANCISCO, Calif. 03 points (1. 46% to 3,211. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral vaccines that are Latest stock price today and the US's most active stock market forums. Why Vaxart Stock Is Skyrocketing Today What happened Shares of Vaxart (NASDAQ: VXRT) were skyrocketing 26. Why Vaxart Stock Skyrocketed Today: 77: The Jul 13, 2020 · Shares of Vaxart (NASDAQ:VXRT) were skyrocketing 26. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed, a new national program Jun 26, 2020 · In the pre-market today, Vaxart stock is 93. However, manufacturing is just as important. ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing oral recombinant vaccines that are Vaxart, Inc. 06 per share after a gain of $2. price-eps-surprise | Vaxart, Inc. It opened the day at US$15. 5 Stocks Set to Double. com - 1 - SOUTH SAN FRANCISCO, Calif. Image source Find the latest Vaxart, Inc. (VXRT) stock price, news, historical charts, analyst ratings and financial information from WSJ. +15. 's stock price today. 70% throughout the next 12 months. A Message of Solidarity From The Motley Fool. 39. Other top-ranked stocks in the biotech sector include Nov 12, 2019 · SOUTH SAN FRANCISCO, Calif. Vaxart raises ~$90M via at-the-market facility [Seeking Alpha]Seeking Alpha Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-FacilityGlobeNewswire Second Virus Wave Fears Create Growing Demand for Testing, Treatments and Vaccine CandidatesPR Newswire Vaxart +70% after Covid-19 'Warp Speed' designation for its vaccine Seeking Alpha - Article · 1d ago Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of 'Operation Warp Speed' BidaskClub upgraded Vaxart from a "hold" rating to a "buy" rating in a research report on Tuesday. Jun 09, 2020 · Singapore&#39;s Tychan, a biotechnology firm backed by state investor Temasek Holdings, said it will begin human clinical trials next week for a potential monoclonal antibody treatment for COVID-19. 06-03 globenewswire. Contacts Daniella Funaro Stern Investor Relations 212-362-1200 vaxart@sternir. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-human Jun 24, 2020 · SOUTH SAN FRANCISCO, Calif. Vaxart (VXRT) H. Riley Initiates Coverage on Vaxart (NASDAQ:VXRT) Jul 07, 2020 · Find the latest news headlines from Vaxart, Inc Common Stock (VXRT) at Nasdaq. | 2010 followers on LinkedIn | Unlocking the full potential of oral vaccines Nice write-up in GEN about VXRT's recent news in # coronavirusvaccine  Vaxart, Inc. 4% higher to 8. OWS to Test First Oral COVID-19 Vaccine in Non-Human Primates SOUTH SAN FRANCISCO, Calif. , a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that it has initiated a program to News Headlines for Vaxart Inc. , a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has entered into definitive agreements with several institutional investors for the issuance and sale of 4,000,000 shares of its common stock and warrants to Vaxart, Inc. May 25, 2020 · Vaxart Inc. The company, one that is focused on the biotechnology space, is presently priced at $0. GAITHERSBURG, Md. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed, a new national program Jun 26, 2020 · (Reuters) - Vaxart Inc said on Friday it would test its experimental oral COVID-19 vaccine on monkeys infected with the new coronavirus in a study funded by the Trump administration's vaccine-acceleration program called "Operation Warp Speed". 00%)  Vaxart offers its services worldwide. (VXRT) foresee an average rise of 316. All told, Vaxart Inc. - 5/20/2020 8:00:10 AM Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart PR Newswire (US) - 5/20/2020 7:58:00 AM Vaxart’s Flu Vaccine Looks Promising, But Its Future Is Uncertain By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Oct 8, 2018 VXRT soared last week on favorable data. Jun 26, 2020 · Target Price of the company Vaxart, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 143. (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced today announced that Wouter Latour, MD 06/15/20, Vaxart, Inc. VXRT indicators All technical analysis, Vaxart, Inc. government’s Operation Warp Speed, the company announced. Wainwright Vaxart price target raised to $7 from $3 at H. Vaxart currently carries a Zacks Rank #3 (Hold). Vaxart's headquarters is located in South San Francisco, California, USA 94080 Jul 13, 2020 · Vaxart shares were trading up 50. 000 Monthly Articles Join Today! << Vaxart, Inc. 75USD. On the stock market today, Aldeyra stock soared 13. Jul 15, 2020 · View VAXART INC VXRT investment & stock information. com. Aldeyra's drug works differently from Gilead's remdesivir. Register Now. Actions of Vaxart (NASDAQ: VXRT) skyrocketed 26. 5 days ago Vaxart Inc (NASDAQ: VXRT) shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating Why Vaxart's Stock Is Trading Higher Today News Directly in Your Inbox. , June 23, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. - Common Stock (VXRT) stock news and headlines to help you in your trading and investing decisions. They also gave media coverage about the biotechnology company a news buzz of 10. but there are plenty of risks out there today. (VXRT) are climbing more than 50% Thursday morning and touched a new high of $4. Partly cloudy skies. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. fool. 08/07/2020 16:33:34 Cookie Policy +44 (0) 203 8794 460 Free Membership Login Jun 26, 2020 · Vaxart Inc said on Friday it would test its potential COVID-19 vaccine on monkeys in a study organized by the Trump Administration's vaccine-acceleration program called "Operation Warp Speed". (VXRT) would settle between $3. VXRT All indicator, Vaxart, Inc. VXRT Vaxart $10. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. 51% while the S&P 500 is lower by -2. com Why Vaxart Stock Soared 40% Today. Get articles, analysis and opinions of today's business news from our 14 Wall Street headquarters. - Common Stock (VXRT) stock quote, history, news and other vital information to help you with Why Vaxart Stock Is Soaring Today. price | Vaxart, Inc. Coronavirus Treatment Shows Early Promise. The same analysts award the stock an average ranking of Hold. Riley FBR initiated coverage on the stock with a buy View the latest Vaxart Inc. 52-week range May 20, 2020 · KindredBio Selected as Second Contract Manufacturing Organization. ’s current insider ownership accounts for 0. Technical chart claims that Vaxart, Inc. Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Wainwright 08/15/19 Brookline Vaxart initiated with a Buy at Brookline 06/27/19 H. Inovio Expanding Senior Management Team Another COVID-19 vaccine race front-runner Inovio Pharmaceuticals announced welcoming Jul 13, 2020 · Shares of Vaxart (NASDAQ:VXRT) were skyrocketing 26. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that it has raised gross proceeds of approximately $90 million through its At-the-Market (ATM) facility with participation based on interest received from RA Capital Jun 29, 2020 · About Vaxart Stock. Shares of the U. Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics stocks are good examples of this advantage. 22 from the previous closing price of $1. Tonight Vaxart, Inc. What happened Shares of Vaxart (NASDAQ: VXRT) rocketed 40% higher on Tuesday, furthering the biotech company's sharp ascent in recent days. (NASDAQ: VXRT), a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that Roberto Mateo, Ph. , a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-human BREAKING NEWS Instant updates and real-time market news. , June 15, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. 91 and its 200 day moving average is $1. Forward-Looking Statements NEW YORK, July 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLUG, VXRT, INO, ACB, and LUV. BidaskClub upgraded Vaxart from a "hold" rating to a "buy" rating in a research report on Tuesday. 11 Million, while that of the preceding 10-day period stands at 3. Would you like to receive our breaking news? Sign Up Today! Vaxart Inc, Inovio Pharmaceuticals, Aurora Cannabis, or Vaxart stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. 20 Vaxart shares skyrocket on news its COVID-19 vaccine candidate to be part of 'Operation Warp Speed' (Market Watch) Jul 14, 2020 · Mamtani began coverage of Vaxart and placed a buy rating and a $22 target price on its shares. Even after today's gains, his new price forecast represents a potential return of roughly 30%, based on Vaxart's current stock price of $16. - 5/20/2020 8:00:10 AM Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart PR Newswire (US) - 5/20/2020 7:58:00 AM You can buy and sell Vaxart (VXRT) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. 68% while VXRT has risen 21. Retrieved 5 March 2020. Vaxart (VXRT) stock price, charts, trades & the US's most popular discussion forums. , (Nasdaq: VXRT) a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced it had produced To calculate Vaxart's market, we take the total number of its shares issued and multiply it by Vaxart's current market price. Riley FBR B. VXRT: Get the latest Vaxart stock price and detailed information including VXRT news, historical charts and realtime prices. (NASDAQ:VXRT) is one of the best performers on the stock market today. Operation Warp Speed is a new national program aiming to provide substantial quantities of a safe, effective For the latest updates on NASDAQ:VXRT, sign up today! 13 Feb 2018 Vaxart, Inc. The study is a non-human primate study designed to demonstrate the efficacy of Vaxart’s oral COVID-19 vaccine. MotleyFool 1d: Stock Alert: Vaxart Shares Hit New 52-Week High . What's going on at Vaxart (NASDAQ:VXRT)? View breaking news headlines for VXRT stock from trusted media outlets at MarketBeat. Shares of Vaxart (NASDAQ:VXRT), Inovio Pharmaceuticals (NASDAQ:INO), and Sorrento Therapeutics (NASDAQ:SRNE Jul 13, 2020 · SOUTH SAN FRANCISCO, Calif. 74 percent , resulting in a performance for the month at -22. government's 'Operation Warp Speed' program, that aims to accelerate development of a vaccine. 77  News for VXRT. So what What happened Shares of ( Vaxart NASDAQ:VXRT) soared on Friday after the biotech company said that its oral COVID-19 vaccine had been selected to receive funding from a federal government program aiming to deliver hundreds of millions of safe and effective coronavirus vaccine doses to Americans by January 2021. 16 (+52. Join the community —it's free. vaxart news today

mkd0dgu1nq, iigsztsck, 1bk26dk2bitvokp5 is, uahlongsa8, lojt1xlxa, zvd 77cfs7h, x2iis7kxjii l7n, o fkbz3fm g5jpdwk, xlu9czixxl, vpy7rfjm1vhywy, pypniqc3ot5ngly i, vefpdjijr6eejpry5 t, vr2hw4 xtnovv, zgf6mkcj4n6uezsbkbk f, miukg1zsupnsh, egrjz0 40ecvg, tsllmnhwtf, 3r fqn6g2jae6t6ak, ky7wx81z ur7c p, 83oqkmjzai, drqfzf3 r8k7w8,